These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25465890)

  • 41. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
    Blumenthal PD; Voedisch A; Gemzell-Danielsson K
    Hum Reprod Update; 2011; 17(1):121-37. PubMed ID: 20634208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors that influence the choice of long-acting reversible contraceptive use among adolescents post-abortion in Chongqing, China: a cross-sectional study.
    Jin F; Yang Y; Sun J; Li R; Yao F; Liu X
    J Obstet Gynaecol; 2024 Dec; 44(1):2316625. PubMed ID: 38353518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
    Smith AJB; Harney KF; Singh T; Hurwitz AG
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Public funding for contraceptive, sterilization and abortion services, 1994.
    Sollom T; Gold RB; Saul R
    Fam Plann Perspect; 1996; 28(4):166-73. PubMed ID: 8853282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Family planning in Russia in 1993-94: the role of NGOs in demonopolising population policy.
    Popov AA
    Plan Parent Eur; 1995 Aug; 24(2):26-30. PubMed ID: 12290801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rethinking Medicaid Coverage and Payment Policy to Promote High Value Care: The Case of Long-Acting Reversible Contraception.
    Vela VX; Patton EW; Sanghavi D; Wood SF; Shin P; Rosenbaum S
    Womens Health Issues; 2018; 28(2):137-143. PubMed ID: 29329988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating the fertility effect of expansions of publicly funded family planning services in California.
    Foster DG; Biggs MA; Rostovtseva D; de Bocanegra HT; Darney PD; Brindis CD
    Womens Health Issues; 2011; 21(6):418-24. PubMed ID: 21802962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Highly Effective Reversible Contraception in Title X Clinics: Variation by Selected State Characteristics.
    Hale N; Khoury A; Smith M
    Womens Health Issues; 2018; 28(4):289-296. PubMed ID: 29661696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional variation in postabortion initiation of long-acting reversible contraception in New Zealand.
    Rose SB; Garrett SM
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):315-22. PubMed ID: 27060549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advocating for immediate postpartum LARC: increasing access, improving outcomes, and decreasing cost.
    Rodriguez MI; Evans M; Espey E
    Contraception; 2014 Nov; 90(5):468-71. PubMed ID: 25107639
    [No Abstract]   [Full Text] [Related]  

  • 51. Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion.
    Goldstone P; Mehta YH; McGeechan K; Francis K; Black KI
    Med J Aust; 2014 Oct; 201(7):412-6. PubMed ID: 25296065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uptake and adherence to long-acting reversible contraception post-abortion.
    Rose SB; Lawton BA; Brown SA
    Contraception; 2010 Oct; 82(4):345-53. PubMed ID: 20851228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abortion in the framework of family planning in Estonia.
    Karro H
    Acta Obstet Gynecol Scand Suppl; 1997; 164():46-50. PubMed ID: 9225637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How has contraceptive provision at Family Planning clinics in Aotearoa New Zealand changed between 2009, 2014 and 2019: a cross-sectional analysis.
    Messenger B; Beliveau A; Clark M; Fyfe C; Green A
    N Z Med J; 2021 Jul; 134(1539):21-32. PubMed ID: 34320612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contraceptive development and better family planning.
    Segal SJ
    Bull N Y Acad Med; 1996; 73(1):92-104. PubMed ID: 8804742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Provision of no-cost, long-acting contraception and teenage pregnancy.
    Secura GM; Madden T; McNicholas C; Mullersman J; Buckel CM; Zhao Q; Peipert JF
    N Engl J Med; 2014 Oct; 371(14):1316-23. PubMed ID: 25271604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Georgia's Medicaid Family Planning Waiver: Working Together with Title X to Enhance Access to and Use of Contraceptive and Preventive Health Services.
    Dunlop AL; Adams EK; Hawley J; Blake SC; Joski P
    Womens Health Issues; 2016; 26(6):602-611. PubMed ID: 27599676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice.
    Langston AM; Joslin-Roher SL; Westhoff CL
    Contraception; 2014 Feb; 89(2):103-8. PubMed ID: 24309218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period.
    Zerden ML; Tang JH; Stuart GS; Norton DR; Verbiest SB; Brody S
    Womens Health Issues; 2015; 25(6):616-21. PubMed ID: 26212318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision.
    Sufrin C; Oxnard T; Goldenson J; Simonson K; Jackson A
    Perspect Sex Reprod Health; 2015 Dec; 47(4):203-11. PubMed ID: 26484795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.